Go to main site

Memento

[ Fondation Leenaards | Research funding on translational medical research ]

Thumbnail

Event details

Date and time 13.05.2019  
Category Call for proposal

Each year, Fondation Leenaards allocates up to CHF 1.5 million for the Leenaards Prize for Translational Medical Research.
 
The research prize is awarded to 2-3 innovative projects, conducted by, at least, a university hospital (CHUV, HUG) and an academic partner (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva region, investigating a clinical problem from an original and innovative angle, linking it to a component of advanced basic research, be it experimental research, bioinformatics or epidemiological analyses.
 
The project must:

  • include a human research component
  • stand on its own, but it can be embedded in the context of an existing project.
 
Who can apply:
  • At least one group at a university hospital (CHUV or HUG) AND one group at an academic institution (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva Region; the third applicant can be based outside of this region.
  • The PI must be a clinical scientist (MD, MD-PhD, or PhD, below the age of 45).
  • Applicants should preferably be at a relatively early stage in their careers.
  • All applicants must hold a “stable position” for the entire duration of the project.
  • Applicants cannot have received this grant during the last 3 years (2016-2018).
 
Funding and duration: Max. 750’000 for up to 36 months (not renewable).
 
Deadlines:
  1. Deadline for Letter of Intent: 11 March 2019.
  2. Pre-selection: 15 April 2019.
  3. Internal deadline for Institutional Support Letter: 13 May 2019 (contact research@epfl.ch)
  4. Deadline for Full Proposals: 27 May 2019
  5. Final Decision: end of September 2019.
  6. Beginning of the Project: early January 2020.
 
For more information have a look at the call webpage, call document, the EPFL Toolkit, composition of the Jury and past granted projects.
 

Practical information

  • General public
  • Free

Contact

Tags

research funding

Event broadcasted in

Share

Login